Chih-Teng Yu

2.5k citations
24 papers · 1.9k indexed · 1 hit paper · h-index 16

Chih-Teng Yu

24 papers receiving 1.9k citations

Hit Papers

Cetuximab plus chemotherapy in patients with advanced non...1.0k20092026201420202505007501000

Peers

Chih-Teng Yu
Comparison fields: 5 of 98
  • Oncology 1.1k
  • Pulmonary and Respiratory Medicine 1.1k
  • Immunology 466
  • Cancer Research 195
  • Anesthesiology and Pain Medicine 58
Replace Harry Raftopoulos with:
Harry Raftopoulos United States
Motoo Nomura Japan
Jianhua Zhan China
Laura Pala Italy
Yoshihiro Nabeya Japan
Shun-ichi Watanabe Japan
Junichiro Hiro Japan
Y-J. Bang South Korea
Shingo Takanashi Japan
Chih-Teng Yu relative to Harry Raftopoulos United States Harry Raftopoulos's profile →
Citations per field
00.5×1.5×
Harry Raftopoulos · 1×
Citations per year

Countries citing papers authored by Chih-Teng Yu

Since Specialization
Citations

This map shows the geographic impact of Chih-Teng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Teng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Teng Yu more than expected).

Fields of papers citing papers by Chih-Teng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Teng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Teng Yu. The network helps show where Chih-Teng Yu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chih-Teng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chih-Teng Yu Line = papers co-authored together Chih-Teng Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201516
2 20144
3 201319
4 20124
5 2012137
6 201191
7 201115
8 201111
9 20104
10 201024
11
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialbreakdown →
20091046
12 2009267
13 200623
14 200611
15 20032
16 200113
17 200057
18 199616
19 199538
20 199424

About Chih-Teng Yu

Chih-Teng Yu is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Tracheal and airway disorders (7 papers), Immune Response and Inflammation (5 papers), Respiratory Support and Mechanisms (4 papers), Immune cells in cancer (4 papers), Asthma and respiratory diseases (4 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers) and Esophageal and GI Pathology (3 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (466 citations). Chih-Teng Yu has collaborated with scholars based in Taiwan, United States and Austria. Frequent co-authors include Han-Pin Kuo, Joachim von Pawel, U. Gatzemeier, Rodryg Ramlau, Filippo de Marinis, Emilio Bajetta, Thomas Goddemeier, Maciej Krzakowski, Aleksandra Szczęsna and Jose R. Pereira. Their work appears in journals such as The Lancet, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026